Clinical Trials
33 trialsNatural History of and Specimen Banking for People With Tumors of the Central Nervous System
National Institutes of Health Clinical Center (CC)
Whole-Brain Tumor Burden Metrics with Inflammatory and Molecular Markers to Predict Postoperative Neurocognitive Decline in Glioma
West China Hospital
ROOT
Taproot Health
Impact of IDH Mutation and Adjuvant Chemo(radio)therapy on Survival Outcome in Grade II/III Astrocytoma
Suez Canal University
RIGEL
Erasmus Medical Center
Social Determinants of Health in Glioblastoma Population
Wake Forest University Health Sciences
Biomarkers for Prognosis of Glioblastoma (GBM)
University of Nebraska
Quality of Life and Patient Needs in Advanced High Grade Gliomas
Henry Ford Health System
Immunophenotyping From Blood of Patients With Malignant Gliomas
University of Erlangen-Nürnberg Medical School
Clinical Development of Cancer-Specific MRS Biomarkers in Malignant Gliomas
University of Texas Southwestern Medical Center
Clinical Development of MR Spectroscopy and Imaging in Brain Cancers
University of Texas Southwestern Medical Center
Qualitative, Qualitative, and Functional Studies Over the First Year in Measuring Immune System Response During the First Year of Therapy in Patients With Brain Tumors
Wake Forest University Health Sciences
Acute Side Effects in Patients Who Are Undergoing Stereotactic Radiosurgery for Brain Tumors or Other Brain Disorders
Case Comprehensive Cancer Center
Natural History of Patients With Brain and Spinal Cord Tumors
National Institutes of Health Clinical Center (CC)
Study of Blood and Cheek Cell Samples From Patients With Glioma
University of California, San Francisco
Study of Tissue and Blood Samples From Patients With High-Grade Glioma
Alliance for Clinical Trials in Oncology
Radiomics
Maastricht Radiation Oncology
Collecting and Storing Blood and Brain Tumor Tissue Samples From Children With Brain Tumors
Children's Oncology Group
Risk Factors for Developing a Blood Clot in Patients Who Are Undergoing Cancer Treatment for Newly Diagnosed Gliomas
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Changes in Semen or Sperm Caused by Temozolomide in Patients With Newly Diagnosed, Progressive, or Recurrent Primary Malignant Brain Tumors
Wake Forest University Health Sciences
Temozolomide All-Case-Registered Surveillance (Designated Drug Use Investigation)(Study P05062)
Merck Sharp & Dohme LLC
Study of Tissue and Blood Samples From Patients With Low-Grade Glioma
Alliance for Clinical Trials in Oncology
Study of Tissue Samples From Patients With Glioma or Other Brain Tumors
University Hospital, Montpellier
Decision Making About Participating in Pharmacokinetic Studies in Patients Enrolled in a Phase I Treatment Clinical Trial
Children's Oncology Group
Genetic Study in Patients Receiving Treatment for Hodgkin's Disease or Childhood Brain Tumor
Duke University
Natural History of Brain Function, Quality of Life, and Seizure Control in Patients With Brain Tumor Who Have Undergone Surgery
Radiation Therapy Oncology Group
Temodal (Temozolomide) Post Marketing Surveillance Protocol (Study P05557AM2)
Merck Sharp & Dohme LLC
Fatigue, Sleep and Cytokines in Primary Brain Tumor (PBT) Patients
M.D. Anderson Cancer Center
Metabolic Syndrome in Childhood Cancer Survivors
University of Minnesota
Development of Strategies to Increase Enrollment in Clinical Trials for Children With Cancer
Children's Oncology Group
Study of Blood Samples and Risk of Infection in Patients With Newly Diagnosed Malignant Supratentorial Astrocytoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Detecting Malignant Brain Tumor Cells in the Bloodstream During Surgery to Remove the Tumor
National Institutes of Health Clinical Center (CC)
Nimotuzumab in Children With HGG
Oncoscience AG